Atherosclerosis is a chronic inflammatory vascular disease that is characterized by the
accumulation of lipids and immune cells in plaques built up inside artery walls.
Docosahexaenoic acid (DHA, 22: 6n-3), an omega-3 polyunsaturated fatty acid (PUFA),
which exerts anti-inflammatory and antioxidant properties, has long been purported to be of
therapeutic benefit to atherosclerosis patients. However, large clinical trials have yielded
inconsistent data, likely due to variations in the formulation, dosage, and bioavailability of …